Praxis Precision Medicines Inc Long-term Investment Intensity
Praxis Precision Medicines Inc long-term investment intensity. Praxis Precision Medicines Inc (PRAX) has a Long-term Investment Intensity of 45.3% as of March 2026. Long-term investments of $660.94 Million represent 45.3% of total assets of $1.46 Billion. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. See working capital position of Praxis Precision Medicines Inc to evaluate short-term liquidity relative to the company's equity base.
LT Investment Intensity
Long-term Investments
Total Assets
Country
Long-term Investment Intensity of Praxis Precision Medicines Inc (2024–2025)
Long-term investment intensity of Praxis Precision Medicines Inc from 2024 to 2025. This chart shows how Praxis Precision Medicines Inc's Long-term Investment Intensity has evolved across 2 annual periods from 2024 to 2025. As of March 2026, the intensity stands at 45.3%, reflecting long-term investments of $660.94 Million against total assets of $1.46 Billion USD. See operational self-sufficiency of Praxis Precision Medicines Inc to measure how many days the company can operate on defensive assets alone.
Praxis Precision Medicines Inc Long-term Investment Intensity by Year (2024–2025)
Praxis Precision Medicines Inc long-term investment intensity by year from 2024 to 2025. The table below presents the year-by-year Long-term Investment Intensity for Praxis Precision Medicines Inc from 2024 to 2025, covering 2 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. For the complete balance sheet picture, see Praxis Precision Medicines Inc assets under control.
| Year | LT Investment Intensity | LT Investments (USD) | Total Assets | Change (pp) |
|---|---|---|---|---|
| 2025 | 34.8% | $326.76 Million | $937.91 Million | ▲ +18.9 pp |
| 2024 | 15.9% | $76.96 Million | $483.11 Million | — |